Summary & Overview
CPT 84437: Thyroxine Measurement From Eluted Neonatal Whole Blood
CPT code 84437 designates a laboratory assay for measuring thyroxine (T4) in specimens that require elution, a process commonly applied to neonatal dried blood spots. The code captures a technical pre-analytic step and quantitative analysis necessary for neonatal thyroid screening and other clinical contexts where whole blood has been absorbed to a substrate and must be recovered for testing. Nationally, accurate coding for this procedure supports newborn screening programs, laboratory reporting, and consistent payment across facilities.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a clinical context for when elution-based T4 testing is used, an outline of typical sites of service (clinical and hospital laboratories), and practical information about common modifiers and billing considerations. The publication also provides benchmark-oriented content and policy updates relevant to laboratory billing and newborn screening workflows. This summary equips laboratory managers, coding professionals, and policy staff with a concise reference on CPT code 84437, its clinical role, and the payer landscape affecting reimbursement and claims processing.
Data not available in the input: Associated taxonomies, ICD-10 diagnoses, related codes, and detailed service line information.
Billing Code Overview
CPT code 84437 describes a laboratory procedure in which a lab analyst measures thyroxine (T4) in specimens that require elution — the process of washing whole blood from an absorbent material using a solvent. This method is typically used for neonatal whole blood specimens collected on absorbent filter paper (dried blood spots) that must be eluted before assay.
Service Type: Laboratory test — quantitative thyroxine measurement after elution
Typical Site of Service: Clinical laboratory or hospital laboratory
Clinical & Coding Specifications
Clinical Context
A typical patient is a newborn in the neonatal nursery or neonatal intensive care unit (NICU) requiring screening for congenital hypothyroidism. The clinical workflow begins with a heel-stick blood collection onto absorbent filter paper to create a dried blood spot. The specimen is transported to the laboratory where the technologist elutes whole blood from the filter paper using a solvent. The laboratory performs a thyroxine (T4) assay on the eluted specimen to quantify total thyroxine for screening or diagnostic confirmation. Results are reported to the newborn screening program, the neonatology team, and the primary pediatrician. Abnormal or borderline results prompt reflex testing (repeat dried blood spot or serum testing), clinical notification, and potential endocrine consultation for evaluation and management of suspected congenital hypothyroidism or other thyroid function abnormalities.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Principal physician/performing practitioner | When a physician is the primary reporting provider for the laboratory service in settings requiring a physician provider indicator |
26 | Professional component | When billing only the professional interpretation component of a split-service laboratory test (rare for automated T4 assays) |